48.JPG)
The Global Cell Free RNA Isolation & Extraction Kits Market Size is valued at USD 41.55 million in 2023 and is predicted to reach USD 123.94 million by the year 2031 at a 14.90% CAGR during the forecast period for 2024-2031.
Key Industry Insights & Findings from the Report:
- The increasing elderly population, increased public understanding of healthcare, and growing cancer cases drive the market growth.
- Rising advancements in healthcare technology and government support are expected to drive industry growth.
- North America dominated the market and accounted for a global revenue share in 2023.
- A significant barrier is extensive legal mandates and high costs, slowing market growth.
RNA extraction kits isolate the RNA from any cell, which can be extracted from an animal, a bacterium, or a plant. These extractions are mostly used for RNA profiling different species to comprehend them better and, in certain cases, to identify the unidentified organism. Technological developments, the introduction of new products by major market participants, and increasing cancer incidence worldwide may also aid the market's expansion.
A decline in patient turnout for testing as a result of COVID-19 has had an impact on the diagnostic tests for other diseases and medical disorders in hospitals and other clinical diagnostics establishments. However, the high COVID-19 infection rate and important local company research initiatives raising rates of various cancer kinds and an increase in cases of prenatal problems are the main factors driving the market development.
The market for cell-free RNA isolation and extraction kits is well-established. It plays a significant role in medical decision-making by assisting in gathering data for disseminating various treatments, underscoring its importance in healthcare. A growing elderly population base, extensive research & innovation, patient population knowledge of non-invasive and minimally invasive procedures, increased government funding, and technical improvements are further drivers boosting the market's growth.
Recent Developments:
- In February 2022- A technological commercialization partnership agreement between Zinexts Life Science Corp. and JBS Science, Inc. is signed, allowing Zinexts to produce and market JBS nucleic separation kits, including cfDNA and RNA isolation kits. Access to JBS NA Zinexts' isolation automation systems and equipment will be made simpler by this license agreement.
- In October 2020- Cells to Pure DNA Low Input Kit, a DNA extraction kit for researchers dealing with constrained biological material was introduced by Purigen Biosystems Inc
Competitive Landscape:
Global cell-free RNA isolation & extraction kits market players are:
- Aline Biosciences
- Apostle Inc. (Apostle Sciences)
- Danagen-Bioted, S.L.
- Hoffmann-La Roche Ltd.
- JBS Science Inc.
- Norgen Biotek Corp
- PerkinElmer, Inc.
- Promega Corporation
- QIAGEN N.V.
- Streck, Inc.
- Takara Bio Inc.
- Thermo Fisher Scientific Inc.
- Zymo Research Corporation
Market Segmentation:
The cell-free RNA isolation & extraction kits market is segmented on the applications and end-use. The market is segmented based on applications: oncology, prenatal screening, metabolic disorders, and others. Based on end-use, the market is further segmented into hospitals & clinics, pharmaceutical & biotechnology companies, and others.
Based On End Users, The Parental Screening Segment Is A Major Contributor To The Cell-Free RNA Isolation & Extraction Kits Market
The market's leading segment is parental screening. The use of non-invasive methods like cell-free RNA, which aids in predicting prenatal problems, is advancing quickly. Cell-free RNA can be used to describe and predict prenatal problems such as intrauterine growth restriction (IUGR), preeclampsia, and spontaneous preterm birth (PTB) (cf RNA). Thus, the rise in demand for cell-free RNA isolation and extraction kits is boosting the market demand due to the rise in women experiencing prenatal problems.
The Hospital & Clinics Segment Witnessed Growth At A Rapid Rate
Hospitals grabbed the highest revenue share, and it is anticipated that they will continue to hold that position during the anticipated time due to the growing need for precise and early disease diagnosis. Techniques for isolating and purifying RNA are thought to be efficient screening tools for hereditary illnesses such as sickle cell anemia, hemophilia A, and Tay-Sachs disease. Therefore, the availability of such effective technologies at moderate to cheap prices will likely improve the adoption rate of these technologies in medical facilities and hospitals.
The North American Cell-Free RNA Isolation & Extraction Kits Market Holds A Significant Regional Revenue Share
The North American cell-free RNA isolation & extraction kits Industry is expected to register the highest market share in revenue soon. The main factor driving market expansion in the area is the presence of established companies and their work on creating technologically cutting-edge fast purification and isolation systems. Additionally, the increasing financing initiatives for biotechnology research are accelerating the market's growth.
In addition, Asia Pacific is projected to grow rapidly in the global cell-free RNA isolation & extraction kits business. Rising economic growth, substantial life sciences research, an increasing patient population, supportive government measures, and numerous creative biotech companies in the area are all factors causing the market in the region to flourish.
Cell Free RNA Isolation & Extraction Kits Market Report Scope:
|
Report Attribute |
Specifications |
|
Market size value in 2023 |
USD 41.55 Mn |
|
Revenue forecast in 2031 |
USD 123.94 Mn |
|
Growth rate CAGR |
CAGR of 14.90% from 2024 to 2031 |
|
Quantitative units |
Representation of revenue in US$ Million, and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report coverage |
The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
|
Segments covered |
Applications And End-Use |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
|
Competitive Landscape |
F.Hoffmann-La Roche AG, JBS Science Inc., Aline Biosciences, Apostle Inc. (Apostle Sciences), Danagen-Bioted, S.L., Norgen Biotek Corp., PerkinElmer, Inc., Promega Corporation, QIAGEN N.V., and Thermo Fisher Scientific Inc. |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
